Charles J Dockendorff Haemonetics Corp (HAE) insider trading activity

Charles J Dockendorff is Director of HAEMONETICS CORP. Currently has a direct ownership of 4,433 shares of HAE, which is worth approximately $387,532. The most recent transaction as insider was on Jul 25, 2024, when has been sold 2,207 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.43K

0% 3M change

99.15% 12M change

Total Value Held $387,532

Charles J Dockendorff Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 25 2024	BUY Grant, award, or other acquisition	-	2,207 Added 33.24%	4,433 Common Stock
Sep 05 2023	SELL Open market or private sale	$895,651 $87.68 p/Share	10,215 Reduced 82.11%	2,226 Common Stock
Aug 04 2023	BUY Grant, award, or other acquisition	-	2,226 Added 15.18%	12,441 Common Stock
Aug 05 2022	BUY Grant, award, or other acquisition	-	2,730 Added 8.85%	28,130 Common Stock
Aug 06 2021	BUY Grant, award, or other acquisition	-	3,077 Added 10.81%	25,400 Common Stock
Feb 04 2021	SELL Open market or private sale	$1,638,575 $134.53 p/Share	12,180 Reduced 46.96%	13,755 Common Stock
Feb 04 2021	BUY Exercise of conversion of derivative security	$432,390 $35.5 p/Share	12,180 Added 31.96%	25,935 Common Stock

Also insider at

HOLX

HOLOGIC INC Healthcare

Director

KEYS

Keysight Technologies, Inc. Technology

Director

BSX

BOSTON SCIENTIFIC CORP Healthcare

Director

CJD